American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2022. Diabetes Care. 2022;45:S17–S38.

Article  Google Scholar 

Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, et al. Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol. 2019;26:25–32.

Article  PubMed  Google Scholar 

Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pr. 2022;183:109119.

Article  Google Scholar 

Giorgino F, Leonardini A, Laviola L. Cardiovascular disease and glycemic control in type 2 diabetes: Now that the dust is settling from large clinical trials. Ann N. Y Acad Sci. 2013;1281:36–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hayfron-Benjamin CF, Maitland-Van Der Zee AH, van den Born BJ, Amoah AGB, Meeks KAC, Klipstein-Grobusch K, et al. Association between C reactive protein and microvascular and macrovascular dysfunction in sub-Saharan Africans with and without diabetes: The RODAM study. BMJ Open Diabetes Res Care 2020;8. https://doi.org/10.1136/bmjdrc-2020-001235.

Pfützner A, Schöndorf T, Hanefeld M, Forst T. High-sensitivity C-reactive protein predicts cardiovascular risk in diabetic and nondiabetic patients: effects of insulin-sensitizing treatment with pioglitazon. J Diabetes Sci Technol. 2010;4:706–16.

Article  PubMed  PubMed Central  Google Scholar 

Abdulhameed LQ, Sultan AA, AL-Mahdawi ZMM. Homocysteine: A recent potential risk factor for type 2 diabetes mellitus patients in Diyala Province. AIP Conf Proc. 2023;2593:050004.

Article  CAS  Google Scholar 

Wu JT. Circulating homocysteine is an inflammation marker and a risk factor of life-threatening inflammatory diseases. J Biomed Lab Sci. 2007;19:107–12.

Google Scholar 

Lala K, Lala D, Duggad S. Serum vitamin B12 and homocysteine levels in type 2 diabetes patients on metformin. Int J Adv Med. 2020;7:1376.

Article  Google Scholar 

Durga J, Van Tits LJH, Schouten EG, Kok FJ, Verhoef P. Effect of lowering of homocysteine levels on inflammatory markers a randomized controlled trial. Arch Intern Med. 2005;165:1388–94.

Article  CAS  PubMed  Google Scholar 

Li T, Chen Y, Li J, Yang X, Zhang H, Qin X, et al. Serum homocysteine concentration is significantly associated with inflammatory/immune factors. PLoS One. 2015;10:e0138099.

Article  PubMed  PubMed Central  Google Scholar 

El Oudi M, Aouni Z, Mazigh C, Khochkar Phd R, Gazoueni Phd E, Haouela H, et al. Homocysteine and markers of inflammation in acute coronary syndrome. Exp Clin Cardiol. 2010;15:e25–e28.

Google Scholar 

Elsherbiny NM, Sharma I, Kira D, Alhusban S, Samra YA, Jadeja R, et al. Homocysteine induces inflammation in retina and brain. Biomolecules. 2020;10:393.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Z, Gu X, Fang X, Tang Z, Guan S, Liu H, et al. Homocysteine and the risk of cardiovascular events and all-cause death in elderly population: a community-based prospective cohort study. Ther Clin Risk Manag. 2020;16:471–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sato S, Tajiri Y, Nakayama H, Yamada K. Folic acid supplementation of aspirin therapy further improves vascular endothelial function among patients with type 2 diabetes: a short-term crossover study. Diabetol Int. 2015;6:284–9.

Article  Google Scholar 

Miyan Z, Waris N. Association of vitamin B 12 deficiency in people with type 2 diabetes on metformin and without metformin: a multicenter study, Karachi, Pakistan. BMJ Open Diabetes Res Care. 2020;8:e001151.

Article  PubMed  PubMed Central  Google Scholar 

Awad NA, Alsaady ZA, Albayati MAM, Mutlak SS. Correlation study of metformin drug with vit.B12 and folic acid in women suffer of type 2 diabetic disease. J Pharm Negat Results. 2022;13:308–12.

CAS  Google Scholar 

Song S, Song BM, Park HY. Associations of serum folate and homocysteine concentrations with all-cause, cardiovascular disease, and cancer mortality in men and women in Korea: the Cardiovascular Disease Association Study. J Nutr. 2023;153:760–70.

Article  CAS  PubMed  Google Scholar 

Ebesunun MO, Obajobi EO. Elevated plasma homocysteine in type 2 diabetes mellitus: a risk factor for cardiovascular diseases. JAMA Netw Open. 2022;5:e2146124.

Google Scholar 

MacGirlley R, Phoswa WN, Mokgalaboni K. Modulatory Properties of Vitamin D in Type 2 Diabetic Patients: A Focus on Inflammation and Dyslipidemia. Nutrients 2023;15. https://doi.org/10.3390/nu15214575.

Qudsia F, Matti HA, Riaz S. Pleiotropic effect of folate-cobalamin combinational therapy on diabetes mellitus. Ann Nutritional Disord Ther. 2020;7:1–8.

Google Scholar 

Fact Sheet for Health Professionals. Folate - Health Professional Fact Sheet https://ods.od.nih.gov/factsheets/Folate-HealthProfessional/ (accessed 28 Oct 2023).

Spoelstra-de MA, Brouwer CB, Terheggen F, Bollen JM, Stehouwer CD, Smulders YM. No effect of folic acid on markers of endothelial dysfunction or inflammation in patientswith type 2diabetes mellitus and mild hyperhomocysteinaemia. J Med. 2004;62:246–53.

Google Scholar 

Talari HR, Rafiee M, Farrokhian A, Raygan F, Bahmani F, Darooghegi Mofrad M, et al. The effects of folate supplementation on carotid intima-media thickness and metabolic status in patients with metabolic syndrome. Ann Nutr Metab. 2016;69:41–50.

Article  CAS  PubMed  Google Scholar 

Fatahi S, Pezeshki M, Mousavi SM, Teymouri A, Rahmani J, Kord Varkaneh H, et al. Effects of folic acid supplementation on C-reactive protein: A systematic review and meta-analysis of randomized controlled trials. Nutr Metab Cardiovascular Dis. 2019;29:432–9.

Article  CAS  Google Scholar 

Kaye AD, Jeha GM, Pham AD, Fuller MC, Lerner ZI, Sibley GT, et al. Folic Acid Supplementation in Patients with Elevated Homocysteine Levels. Adv Ther. 2020;37:4149–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Title LM, Ur E, Giddens K, McQueen MJ, Nassar BA. Folic acid improves endothelial dysfunction in type 2 diabetes - An effect independent of homocysteine-lowering. Vasc Med. 2006;11:101–9.

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:1–9.

Google Scholar 

McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12:55–61.

Article  PubMed  Google Scholar 

Giuliano C, Karahalios A, Neil C, Allen J, Levinger I. The effects of resistance training on muscle strength, quality of life and aerobic capacity in patients with chronic heart failure — A meta-analysis. Int J Cardiol. 2017;227:413–23.

Article  PubMed  Google Scholar 

Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:1–10.

Article  Google Scholar 

Bowden J, Tierney JF, Copas AJ, Burdett S. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med. Res. Methodol. 2011;11. https://doi.org/10.1186/1471-2288-11-41.

Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I 2 Index? Psychol Methods. 2006;11:193–206.

Article  PubMed  Google Scholar 

Moreno SG, Sutton AJ, Ades A, Stanley TD, Abrams KR, Peters JL, et al. Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation study. BMC Med. Res. Methodol. 2009;9. https://doi.org/10.1186/1471-2288-9-2.

Doleman B, Freeman SC, Lund JN, Williams JP, Sutton AJ. Funnel plots may show asymmetry in the absence of publication bias with continuous outcomes dependent on baseline risk: presentation of a new publication bias test. Res Synth Methods. 2020;11:522–34.

Article  PubMed  Google Scholar 

Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–94.

Article  PubMed  Google Scholar 

El-khodary NM, Dabees H, Werida RH. Folic acid effect on homocysteine, sortilin levels and glycemic control in type 2 diabetes mellitus patients. Nutr Diabetes. 2022;12:1–8.

Article  Google Scholar 

Satapathy S, Bandyopadhyay D, Patro BK, Khan S, Naik S. Folic acid and vitamin B12 supplementation in subjects with type 2 diabetes mellitus: A multi-arm randomized controlled clinical trial. Complement Ther Med. 2020;53:102526.

Article  PubMed  Google Scholar 

Gargari BP, Aghamohammadi V, Aliasgharzadeh A. Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes. Diabetes Res Clin Pr. 2011;94:33–38.

Article  CAS  Google Scholar 

Mangoni AA, Sherwood RA, Asonganyi B, Swift CG, Thomas S, Jackson SHD. Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes. Am J Hypertens. 2005;18:220–6.

Article  CAS  PubMed  Google Scholar 

Aghamohammadi V, Gargari P, Aliasgharzadeh A. Effect of folic acid supplementation on homocysteine, serum total antioxidant capacity, and malondialdehyde in patients with type 2 diabetes mellitus. J Am Coll Nutr. 2011;30:210–5.

Article  CAS  PubMed  Google Scholar 

Aarsand AK, Carlsen SM. Folate administration reduces circulating homocysteine levels in NIDDM patients on long-term metformin treatment. J Intern Med. 1998;244:169–74.

Article  CAS  PubMed  Google Scholar 

Zhang X, Qu YY, Liu L, Qiao YN, Geng HR, Lin Y, et al. Homocysteine inhibits pro-insulin receptor cleavage and causes insulin resistance via protein cysteine-homocysteinylation. Cell Rep. 2021;37. https://doi.org/10.1016/j.celrep.2021.109821.

Shen Z, Zhang Z, Zhao W Relationship between plasma homocysteine and chronic kidney disease in US patients with type 2 diabetes mellitus: a cross-sectional study. BMC Nephrol. 2022;23. https://doi.org/10.1186/s12882-022-03045-6.

Lei X, Zeng G, Zhang Y, Li Q, Zhang J, Bai Z, et al. Association between homocysteine level and the risk of diabetic retinopathy: a systematic review and meta-analysis. Diabetol. Metab. Syndr. 2018;10. https://doi.org/10.1186/s13098-018-0362-1.

Zhao W, Chen L, Lin Y, He H, Ma H, Hu Q, et al. Association of homocysteine and insulin resistance with increased risk of mortality in a nondiabetic population: third national health and nutrition examination survey. Metab Syndr Relat Disord. 2022;20:255–63.

CAS  PubMed  Google Scholar 

Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome the Framingham Offspring Study. Diabetes Care. 2001;24:1403–10.